title: Jaundice and kernicterus in the moderately preterm infant.
abstract: Moderate preterm infants remain at increased risk for adverse outcomes, including acute bilirubin encephalopathy (ABE). Evidence-based guidelines for management of hyperbilirubinemia in preterm infants less than 35 weeks' gestational age are not yet optimized. High concentrations of unconjugated bilirubin can cause permanent posticteric neurologic sequelae (kernicterus). Clinical manifestations of ABE in preterm infants are similar to, but often more subtle than, those of term infants. This review outlines clinical strategies to operationalize management of hyperbilirubinemia in moderately preterm infants to meet recently published consensus-based recommendations.
authors.affiliation: Division of Neonatal-Developmental Medicine, Department of Pediatrics, Lucile Packard Children's Hospital, Stanford University School of Medicine, 750 Welch Road #315, Stanford, CA 94304, USA.
authors.forename: Matthew B
authors.initials: MB
authors.lastname: Wallenstein
authors.forename: Vinod K
authors.initials: VK
authors.lastname: Bhutani
mesh_terms: D001663:Bilirubin / Q000097:blood; D032921:Consensus; D006801:Humans; D051556:Hyperbilirubinemia, Neonatal / Q000175:diagnosis / Q000628:therapy*; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000175:diagnosis / Q000628:therapy*; D007567:Jaundice, Neonatal / Q000175:diagnosis / Q000628:therapy*; D007647:Kernicterus / Q000175:diagnosis / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012016:Reference Values
chemical_list: D001663:Bilirubin
keywords: Bilirubin encephalopathy; Bilirubin-induced neurologic dysfunction; Hyperbilirubinemia; Jaundice; Kernicterus; Moderately preterm; Newborn jaundice